Innovative OSA Screening in Head and Neck Cancer Patients with the Apneal App

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests whether the Apneal smartphone application can be used in routine clinical care to diagnose obstructive sleep apnea in patients with suspected head and neck cancer and to monitor sleep apnea over the course of treatment. The approach combines specialized sleep consultation with overnight recording using the Apneal app. Eligible participants are adults undergoing diagnostic workup for a suspected head and neck cancer lesion and who later have a confirmed malignant lesion, with consent and social security affiliation required. The study is conducted at CHU Caen in Caen, France, led by University Hospital, Caen, with Mitral as a collaborator. Safety and feasibility of the app in this clinical context will be assessed as part of routine care integration.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patients undergoing diagnostic workup for a lesion suspected to be a head and neck cancer, followed by confirmation of the malignant nature of the lesion. The following locations will be included: the nasopharynx, nasal cavities, sinuses, oral cavity, oropharynx, hypopharynx, larynx, and parotid gland.
* The collection of the informed consent signature is required.
* The patient must be affiliated with the social security system.

Exclusion Criteria:

* Minor patients, or those under judicial protection, guardianship, or curators.
* Lack of confirmation of the malignant nature of the lesion.
* Diagnosis of metastatic cancer.
* Known history of obstructive sleep apnea syndrome (OSAS) or previously treated head and neck cancer.

Where it's running

• CHU Caen
  Caen, France, France Recruiting

Study contacts

• Study coordinator: Emmanuel MICAULT, Dr
• Email: micault-e@chu-caen.fr
• Phone: +33231065461

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cough Skill Training to Help Head and Neck Cancer Patients Recover Voluntary Cough

  Researchers will test whether a handheld cough device-based training can help people with head and neck cancer improve their voluntary cough function.

  Recruiting Boston University Charles River Campus · Boston, Massachusetts · NCT07756684

• HMB Supplements to See If they Help Inflammation and Recovery After Head and Neck Cancer Surgery

  This study tests whether taking HMB before surgery can reduce inflammation and improve recovery for adults with head and neck cancer undergoing tumor removal.

  Recruiting Federal University of Minas Gerais · Belo Horizonte, Minas Gerais · NCT07675421

• Dietary fiber and sarcopenia risk in head and neck cancer

  This observational study will track fiber intake and related biological markers in adults with head and neck cancer from diagnosis for six months to see if higher fiber intake relates to better muscle health and lower inflammation during treatment.

  Recruiting University of Oklahoma · Oklahoma City, Oklahoma · NCT07622914

• EPI-326 for EGFR-mutant non-small cell lung cancer and head and neck squamous cell carcinoma

  This phase 1 trial will try EPI-326, a new drug, in people with EGFR-mutant non‑small cell lung cancer or advanced head and neck squamous cell carcinoma to find safe doses, study how the body handles it, and look for early signs it shrinks tumors.

  Recruiting at 8 sites Phase 1 EpiBiologics · Los Angeles, California and 7 other locations · NCT07462377

• Group program to promote post-traumatic growth for adults with breast, colorectal, or head and neck cancer in Greece

  This project will try a manualized, group-based ACT program to help Greek adults who finished chemotherapy for breast, colorectal, or head and neck cancer increase post-traumatic growth and quality of life.

  Recruiting Centre for Research and Technology Hellas · Thessaloniki · NCT07108517

• Telemedicine follow-up for early laryngeal cancer patients

  This study tests if follow-up care through Telemedicine is just as good as in-person visits for people with early laryngeal cancer, especially for those who live far from treatment centers.

  Recruiting University Medical Center Groningen · Groningen, Provincie Groningen · NCT06940505

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.